Podcasts about lumiata

Send us a textOn the nostalgic grounds of their shared alma mater, Wharton, Simi speaks with Dilawar Syed, the Deputy Administrator of the U.S. Small Business Administration (SBA). A role he was nominated into by President Biden, Administrator Syed was the highest-ranking Muslim official in the U.S. Government at the time of this recording. WATCH IT ON YOUTUBE.Syed came to the SBA from the State Department where he served as Special Representative for Commercial & Business Affairs. As the State Department's top commercial diplomat, Deputy Administrator Syed advocated for U.S. companies to compete and win abroad and helped ensure U.S. competitiveness in markets across the globe. Before joining the Biden Administration, Syed held the roles of CEO at Lumiata, an AI healthcare company, and President at software company, Freshworks.  Earlier in his career, Syed oversaw business operations for Yahoo!'s platforms and infrastructure and was a product manager at Siebel Systems and SAP. His transition to public service is marked by civic efforts at the federal, state, and local levels. He was the founding Chair of the California Entrepreneurship Task Force with the Governor's Office, served on President Obama's White House Commission on Asian Americans and Pacific Islanders (AAPIs), and chaired the White House Initiative on AAPIs' Economic Growth Committee. In that role, Syed led the administration's engagement with small businesses across the U.S. after the passage of the American Recovery and Reinvestment Act of 2009. In 2020, Syed was tapped by San Jose Mayor Sam Liccardo to help lead Silicon Valley's pandemic recovery as a member of the Silicon Valley Recovery Roundtable. Syed holds an M.B.A. from Wharton and earned a B.A. in Economics and Computer Science from The University of Texas at Austin.South Asian Trailblazers is an award-winning media platform, community, and agency dedicated to elevating leading South Asians. Join our community at SouthAsianTrailblazers.com. Subscribe to our newsletter to get new episodes and updates on our latest events in your inbox. Follow us @southasiantrailblazers on Instagram, LinkedIn, Facebook, Youtube, and all major podcast platforms, including Apple and Spotify.

Nicolas Tilmans is the cofounder and CEO of Anagenex, an AI-powered drug discovery platform. They have raised $37M in funding so far from investors such as Lux Capital, Khosla Ventures, Air Street, Menlo, and Catalio. He was previously the VP of Engineering at Lumiata. He has a PhD in Biochemistry from Stanford. In this episode, we cover a range of topics including: - What are small molecule drugs and why are they challenging to develop - The founding of Anagenex - Data generation engine - DNA Encoded Libraries (DELs) - Affinity Selected Mass Spectrometry - Identifying the right targets - What's next for AI-infused drug discovery Nicolas's favorite books: - Tomorrow, and Tomorrow, and Tomorrow (Author: Gabrielle Zevin)- Letters by Abraham Lincoln (Author: Abraham Lincoln)--------Where to find Prateek Joshi: Newsletter: https://prateekjoshi.substack.com Website: https://prateekj.com LinkedIn: https://www.linkedin.com/in/prateek-joshi-91047b19 Twitter: https://twitter.com/prateekvjoshi 

This episode's Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: CLICK HERE---Episode Overview: As a passionate and trailblazing digital health physician entrepreneur with a mission to disrupt the healthcare landscape, our next guest combines cutting-edge technologies and insights from diverse industries to empower individuals to live healthier, longer, and more productive lives.Dr. Ravi Komatireddy, Founder and CEO of Daytona Health, joins us to explore his company's groundbreaking approach of leveraging personalized coaching and behavior change techniques to drive positive health transformations. Join us to learn how Dr. Komatireddy's expertise in translational medicine and digital health startups has helped him build his fast-growing company, as well as the inspiring discussion we had about navigating healthcare data, harnessing the power of AI, and driving innovation in the pursuit of a better world. Let's go!Episode Highlights:Dr. Komatireddy shares his journey as a clinician, translational medicine, digital health, and previous startupsWhy Dr. Komatireddy launched Daytona HealthThe challenges of navigating the sea of data in healthcareThe importance of combining technology with human persuasion to turn data into actionable insightsThe potential of machine learning and AI in the coaching spaceAbout our Guest: Ravi Komatireddy, MD, MCTI is a digital health entrepreneur, former Chief Medical Officer, and Board-certified physician with a solid reputation of leveraging cutting-edge technologies and innovations to disrupt the healthcare landscape. He looks outside the field of healthcare to other industries to translate ideas, tools, and solutions into proactive, preventive approaches to medicine that foster health, wellness, performance, and longevity.Ravi creates value by:Delivering Accessible, Affordable Care – Ravi understands and addresses the problems of costly hospital-based care with digital innovations that provide access to people of every gender, race, age, and socioeconomic status. Translating Ideas into Real-World Solutions – Across a wide range of industries, Ravi connects with experts who have successfully ideated and released innovations in the real world. He reframes problems in healthcare and leverages solutions from other fields to move healthcare away from complex, narrow vision to new ways of thinking. Championing Improvements in Human Behavior – Ravi builds intelligent teams of experts and tech solutions that motivate behavior change, resulting in better health and enabling people to be their most productive, disease-free selves.In his current role as the Founder and CEO of Daytona Health, Ravi leads a network of experts to provide ultra-personalized coaching for behavior change and modification, resulting in improved health, longevity, and performance. Daytona Health leverages algorithms, advanced software, sensors, and human data to help its members achieve meaningful, measurable outcomes in metabolic disease, range of motion, energy levels, and stress management.Previously, Ravi co-founded and served as Chief Medical Officer for 2 digital health startups: Reflexion Health and Lumiata. He provided the product vision and clinical oversight to spinout a digital medicine, telehealth physical therapy solution – Reflexion Health – from the Scripps Research Institute and West Health Institute. This was one of the world's first motion tracking-enabled home virtual physical therapy platforms that pioneered the use of consumer devices for FDA-cleared healthcare...

On Health in 2 Point 00, this time we have Jess tell us about OneDrop, Bayer, and SCOR's new partnership, creating a chronic condition-specific life insurance policy using OneDrop's platform and SCOR's risk predictive engine. On Episode 180, Jess asks Matthew about Signify Health filing for IPO – a real IPO, not a SPAC one, Lumiata getting $14 million working on predictive analytics, and Neuroflow getting $20 miillion in a Series A led by Magellan.

Hosts Tammy Hawes and Clark Buckner talk with Dilawar Syed, CEO of Lumiata, about Lumiata’s innovative approach, and how artificial intelligence can help manage the COVID-19 pandemic. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

As votes are still counted in the US, we examine the impact of the election on business. David Taylor runs the Pennsylvania Manufacturers' Association, and explains what the uncertainty may mean in the short term for his members. Dilawar Syed is chief executive of Lumiata, an artificial intelligence healthcare company, and argues the lack of a clear result could lead to instability. Jared Bernstein, who was chief economist to Joe Biden when he was vice-president, and is a member of Mr Biden's transition advisory board, discusses why a landslide victory for Mr Biden, which many polls predicted, did not materialise. And Dr Yu Jie, an expert on China's economy and trade at Chatham House in London, explains how events in the US could impact China. Also in the programme, today the United States formally withdraws from the Paris Accord on Climate Change, which commits countries to reduce emissions of carbon dioxide. Peter Betts was lead negotiator for the EU and UK during the Paris talks, is now a visiting professor at the Grantham Institute, and considers the prospects for future international action on climate change. (Picture: A ballot worker in Michigan. Picture credit: Getty Images.)

In Episode 2 of the MaML Podcast my guest is Miguel Alvarado, CTO of Lumiata, a healthcare AI company based in SF. In this episode, we talk about Miguel’s unconventional journey from Microsoft in the 90s all the way up until the present moment where he is helping bring the power of big data and AI to patients, providers, and insurers. Just like Bruce Wayne, Miguel works during the day, but at night, has an alter ego. we will talk about his passion as an underground house and techno DJ and finally, we will close with a conversation about the importance Of Being PRESENT I had a real pleasure conducting this interview with Miguel and I hope you enjoy it. 00:00 Intro 02:00 Beginnings 12:30 What does Lumiata do 23:40 Synthetic Data 30:00 Explainability in models 34:00 what do you think is the future of AI in medicine 40:00 the importance of being present 44:00 the importance of having other passions 51:00 dj’ing, techno, and being fully present 55:00 machine learning and.. music?!

This episode was recorded from an online event hosted by Wizeline in May 2020. Wizeline CEO Bismarck Lepe moderated a panel with leaders from Etsy, Fitz Frames, and Lumiata on how COVID-19 impacted their business and the creative ways they're helping.

Today's episode features Wizeline CTO Anibal Abarca interviewing Miguel Alvarado, CTO at Lumiata. In this episode, they discuss the role of technology in healthcare, COVID-19 contact tracing, and the promise of 5G technology.

In this episode, Dilawar Syed, CEO of Lumiata, joins Virsys12 CEO and Founder Tammy Hawes to share about the unique ways his company is using artificial intelligence to predict outcomes, interpret data and manage risks in healthcare. In the midst of COVID-19, this work has become more important than ever, and he shares his hope that Lumiata’s models and products will continue to help manage risk and solve high-level problems surrounding the pandemic.

The coronavirus pandemic has forced many small businesses across California to close their doors or drastically change their operations. As the crisis continues to batter the economy, CalMatters reporter Laurel Rosenhall talked on April 2 with Isabel Guzman, the director of the office of Small Business Advocate at GO-Biz, and Dilawar Syed, chair of GO-Biz's Entrepreneurship Task Force and CEO of healthcare AI startup Lumiata, about what the state of California is doing to help struggling entrepreneurs and their businesses.

There are actions our leaders and society can take to combat the coronavirus. Dilawar Syed, President & CEO of Lumiata, discusses steps to fight COVID-19, he shares the role government is playing, plus he unpacks how AI can be part of the solution.

Dilawar Syed, CEO at Lumiata, joins Dollars and Change hosts Katherine Klein and Nick Ashburn to discuss "smarter healthcare" and how the company is producing AI-powered predictive analytics to manage healthcare costs. See acast.com/privacy for privacy and opt-out information.

David Kim, MD, CEO, DigiTx Partners David is the CEO of DigiTx Partners, bringing both business and clinical expertise to venture capital with an extensive background practicing medicine and building healthcare software companies. Most recently, Dr. Kim served as the COO of Lumiata, a venture-backed predictive analytics company positioned at the intersection of data science and medical science. Prior to Lumiata, he spent over a decade as an investor evaluating and growing healthcare companies at MPM Capital and Pinnacle Ventures. Before entering the business sector, David practiced as a general internist and hospitalist at Kaiser South San Francisco where he also served as the Director of Urgent Care and Assistant Chief of Internal Medicine. David completed his internal medicine residency at Harbor-UCLA Medical Center and is a graduate from the Johns Hopkins University School of Medicine (M.D), Stanford Graduate School of Business (M.B.A.), and Pomona College (B.A., Biology). In addition to leading the DigiTx fund, David serves as an active advisor to the Catalyst Program within the UCSF Clinical & Translational Science Institute.

Angie Im is the Director of Customer Success at Lumiata, a company that employs AI-powered analytics to help organizations precisely identify & manage risk at the individual level. Angie has a background at the intersection of healthcare, data, and artificial intelligence, having come out of Carnegie Mellon University and the IBM Watson healthcare team. She joins Kristen to chat about how to apply Customer Success best practices to a Data as a Service company.

On the Wednesday, January 29th 2014 broadcast at 10AM Pacific/1PM Eastern, we begin our special series 'Countdown to HiMSS14' with Ash Damle, CEO of Lumiata (follow on twitter via @lumiata). According to their website, Lumiata is all about: 'helping you deliver optimized care: time . location . behavior . pathophysiology' via 'A New Approach: Predictive analytics powered by an evidence-based medical graph. Striving to combine the brilliance of a physician with the analytic power of big data, we've tied hundreds of healthcare data sets together and spent over 20,000 physician hours to build a medical graph: raw big data processed into usable curated big knowledge.' Ash has been a visible presence in the health innovation conversation for some time now, originally launching the effort via Medgle. Today on this special HiMSS edition we learn more about the man, his vision, passion and value proposition. Join us!